At close: January 2 at 4:00:00 PM EST
After hours: 7:59:55 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-15,382.0000
-17,691.0000
-25,774.0000
-21,933.0000
-12,438.0000
Investing Cash Flow
-67.0000
-93.0000
-268.0000
-1,330.0000
-393.0000
Financing Cash Flow
16,748.0000
10,691.0000
7,853.0000
49,805.0000
8,817.0000
End Cash Position
8,417.0000
5,583.0000
13,184.0000
32,166.0000
5,834.0000
Capital Expenditure
--
-87.0000
-292.0000
-1,360.0000
-393.0000
Issuance of Capital Stock
17,377.0000
9,168.0000
428.0000
53,854.0000
9,019.0000
Issuance of Debt
--
65.0000
7,849.0000
--
--
Repayment of Debt
-715.0000
-697.0000
-424.0000
-289.0000
-74.0000
Free Cash Flow
-15,446.0000
-17,778.0000
-26,066.0000
-23,293.0000
-12,831.0000
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
COEP Coeptis Therapeutics Holdings, Inc.
5.91
+7.45%
NLSP NLS Pharmaceutics AG
2.1800
+3.32%
SPRC SciSparc Ltd.
0.3926
+9.06%
VINC Vincerx Pharma, Inc.
0.2353
-10.46%
PLRZ Polyrizon Ltd.
1.8300
-15.67%
ONCO Onconetix, Inc.
0.6511
+3.35%
VRPX Virpax Pharmaceuticals, Inc.
0.3745
+1.38%
VOR Vor Biopharma Inc.
1.1200
+0.90%
APM Aptorum Group Limited
2.2000
-21.43%
MRNS Marinus Pharmaceuticals, Inc.
0.5340
-0.21%